These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1178 related items for PubMed ID: 15155420

  • 1. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH.
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [Abstract] [Full Text] [Related]

  • 2. Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis.
    Lippi G, Guidi G, Ruzzenente O, Braga V, Adami S.
    Scand J Clin Lab Invest; 1997 Oct; 57(6):507-11. PubMed ID: 9350070
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G, Giada F, Zuliani G, Baroni L, Vitale E, Enzi G, Magnanini P, Fellin R.
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [Abstract] [Full Text] [Related]

  • 5. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
    Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, Fukata S, Amino N, Kuma K, Sasaki I, Hiraiwa T, Hanafusa T, Takamatsu J, Miyauchi A.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
    [Abstract] [Full Text] [Related]

  • 6. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E, Herbeth B, Paille F, Steinmetz J, Artur Y, Siest G.
    Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
    [Abstract] [Full Text] [Related]

  • 7. Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men.
    Hislop MS, St Clair Gibson A, Lambert MI, Noakes TD, Marais AD.
    Atherosclerosis; 2001 Dec; 159(2):425-32. PubMed ID: 11730823
    [Abstract] [Full Text] [Related]

  • 8. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
    Yiğitoğlu MR, Polat MF, Akçay F, Ari Z, Uyanik BS, Ozilgili HM.
    Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
    [Abstract] [Full Text] [Related]

  • 9. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
    Eirís J, Novo-Rodríguez MI, Del Río M, Meseguer P, Del Río MC, Castro-Gago M.
    Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D.
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [Abstract] [Full Text] [Related]

  • 12. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Jul; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
    Zhao S, Li X, Wang Z.
    Hunan Yi Ke Da Xue Xue Bao; 1998 Jul; 23(3):299-301. PubMed ID: 10681765
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M, Kahri J, Pyörälä T, Puolakka J, Luotola H, Lappi M, Lahdenperä S, Taskinen MR.
    Atherosclerosis; 1997 Mar 21; 129(2):249-59. PubMed ID: 9105568
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.